At a Glance
| Detail | Chamelio | Icertis |
|---|---|---|
| Category | CLM | CLM |
| Total raised | $36M | $320M |
| Rounds tracked | 2 | 5 |
| Latest round | Series A, $26M · Sep 2026 | Growth Equity, $50M · Mar 2025 |
| Last valuation | Not disclosed | $2.8B |
| Lead investors | Entree Capital, Work-Bench, Emerge | B Capital, Greycroft, Meritech Capital, Premji Invest |
| Built for | In-house teams | In-house teams |
| Headquarters | United States | US |
Funding, Side by Side
Chamelio rounds
- Sep 2026Series A$26M
- Jan 2026Seed (incl. pre-seed)$10M
Icertis rounds
- Mar 2025Growth Equity$50M
- Mar 2021Series F$80M
- Jul 2019Series E$115M
- Feb 2018Series D$50M
- Mar 2017Series C$25M
Our Take
We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.
Quick Answers
- Which has raised more, Chamelio or Icertis?
- Icertis has raised $320M in disclosed funding, compared with $36M for Chamelio.
- Do Chamelio and Icertis share investors?
- No. None of the investors we track have backed both companies.
- What is Chamelio best for?
- Chamelio is an AI legal platform for in-house teams that automates contract review, negotiation and legal workflows.
- What is Icertis best for?
- Icertis is enterprise contract management software that connects contract data with business systems.
Source: Legal Tech Circle funding data, from public announcements. Updated November 11, 2026.